Pleased to share Ad regarding a great opportunity @BrownMedicine and @Brownsurgical for Chief of the Division of Surgical Oncology. I encourage my qualified interested colleagues to apply and look into this as great things are happening @BrownUniversity and #LegorretaCancerCenter image
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance https://www.nature.com/articles/s41586-025-09916-w
Dana-Farber Cancer Institute awarded $20 million for breast cancer research from Facebook cofounder’s foundation It’s the largest non-federal grant for metastatic breast cancer research at Dana-Farber, officials said. https://www.bostonglobe.com/2025/11/25/metro/facebook-co-founder-grant-dana-farber/
Penn Medicine liable for $12.25 million in cancer misdiagnosis suit, Philadelphia jury says
Penn Medicine liable for $12.25 million in cancer misdiagnosis suit, Philadelphia jury says - The Daily Pennsylvanian
Penn Medicine liable for $12.25 million in cancer misdiagnosis suit, Philadelphia jury says
Penn, and the plaintiff's primary physician, Janos Tanyi, were found liable for 35&#x25...
Nearly One in 10 U.S. Adults Report Having Had Cancer More Americans are living with a cancer diagnosis, reflecting medical progress but also a growing demand for ongoing care
Gallup.com
Nearly One in 10 U.S. Adults Report Having Had Cancer
Nearly one in 10 Americans have been diagnosed with cancer at some point in their lifetime, even as new incidences of cancer are slowly falling.
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer A Meta-Analysis https://jamanetwork.com/journals/jamaoncology/fullarticle/2841671
Novel Bispecific ADC Earns FDA Fast Track Status in Urothelial Cancer
Novel Bispecific ADC Earns FDA Fast Track Status in Urothelial Cancer | CancerNetwork
Investigators are currently assessing the safety and preliminary activity of AVZO-103 among patients with advanced solid tumors in a phase 1/2 trial.
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence https://www.nature.com/articles/s41467-025-65462-z
SeismicπŸ‘‡ NIH shake-up to grant decision-making draws concerns of political meddling Policy drops β€œpaylines” based on peer-review scores and requires geography and other factors to guide approvals https://www.science.org/content/article/nih-shake-grant-decision-making-draws-concerns-political-meddling
HHS Announces Five New Agency Leaders to Advance MAHA Goals https://www.hhs.gov/press-room/hhs-five-new-agency-leaders-maha.html